M. Michael Et Al. , "Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.," American journal of kidney diseases : the official journal of the National Kidney Foundation , vol.81, 2023
Michael, M. Et Al. 2023. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.. American journal of kidney diseases : the official journal of the National Kidney Foundation , vol.81 .
Michael, M., Groothoff, J. W., Shasha-Lavsky, H., Lieske, J. C., Frishberg, Y., Simkova, E., ... Sellier-Leclerc, A.(2023). Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.. American journal of kidney diseases : the official journal of the National Kidney Foundation , vol.81.
Michael, Mini Et Al. "Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.," American journal of kidney diseases : the official journal of the National Kidney Foundation , vol.81, 2023
Michael, Mini Et Al. "Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.." American journal of kidney diseases : the official journal of the National Kidney Foundation , vol.81, 2023
Michael, M. Et Al. (2023) . "Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.." American journal of kidney diseases : the official journal of the National Kidney Foundation , vol.81.
@article{article, author={Mini Michael Et Al. }, title={Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.}, journal={American journal of kidney diseases : the official journal of the National Kidney Foundation}, year=2023}